Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature

Massive vaccination against COVID-19 has become a global priority. Simultaneously, concerns regarding the safety of vaccines are growing. We describe two patients who developed sensory Guillain-Barre syndrome (GBS) shortly after the first dose of the ChAdOx1 vaccine. We also summarize 12 published c...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Young Gi, Ju, Woohee, Ha, Ye-Eun, Ban, Jae-Jun, Lee, Seol Ah, Sung, Jung-Joon, Shin, Je-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349403/
https://www.ncbi.nlm.nih.gov/pubmed/34416410
http://dx.doi.org/10.1016/j.jneuroim.2021.577691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349403/
https://www.ncbi.nlm.nih.gov/pubmed/34416410
http://dx.doi.org/10.1016/j.jneuroim.2021.577691

Ejemplares similares